In Vivo is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

As Pfizer And UCSF Tighten Ties, More Deals With Academia Could Follow

Executive Summary

Pfizer's latest pledge to academic research, a five-year $85 million agreement to fund projects at the University of California, San Francisco, is a sign of the increased importance of deals between pharmas and universities, which give commercial partners access to new research earlier in the development process while nudging academics toward projects with commercial relevance in mind.
Advertisement

Related Content

Leaving UCSF, Desmond-Hellman Will Become Gates Foundation CEO
A New Industry-Academic Model: Novartis And Penn Make A Splash In Cancer Immunotherapy
Sanford-Burnham Medical Research Institute: Making Sure New Drugs Aren't Lost In Translation
Despite Recent Setbacks At Pfizer, R&D Chief Is Optimistic About R&D Innovation
Back To School: Big Pharmas Test New Models For Tapping Academia
Pharmaceutical/Biotechnology Deal Statistics Quarterly, Q4 2010
Pharmaceutical/Biotechnology Deal Statistics Quarterly, Q4 2010
Back To School: Big Pharmas Test New Models For Tapping Academia
A Look Back At 2010: In Search Of New Biopharma Models
Pharma and Academia: Finding New Ways to Join Hands for Mutual Benefit

Topics

Related Companies

Related Deals

Advertisement
UsernamePublicRestriction

Register

IV003420

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel